![]() |
市场调查报告书
商品编码
1938245
发酵原料市场-全球产业规模、份额、趋势、机会及预测(按类型、形态、製程、应用、地区及竞争格局划分,2021-2031年)Fermented Ingredients Market - Global Industry Size, Share, Trends, Opportunity, and Forecast Segmented By Type, By Form, By Process, By Application, By Region & Competition, 2021-2031F |
||||||
全球发酵原料市场预计将从 2025 年的 470.8 亿美元成长到 2031 年的 739.2 亿美元,复合年增长率为 7.81%。
发酵成分,即受控微生物活动产生的代谢物或生物质,用于增强各种产品的风味、营养价值和货架稳定性。这个市场扩张的主要驱动力是食品生产结构向天然和洁净标示保鲜方法的转变,以及工业界对永续蛋白质替代品日益增长的需求。这些因素并非昙花一现,而是源自于对长期供应链永续性的需求以及消费者对合成添加剂的抵制,从而需要对食品生产配方进行永久性调整。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 470.8亿美元 |
| 市场规模:2031年 | 739.2亿美元 |
| 复合年增长率:2026-2031年 | 7.81% |
| 成长最快的细分市场 | 干燥 |
| 最大的市场 | 北美洲 |
然而,该产业面临许多挑战,包括扩大发酵基础设施所需的高额资本投入,以及难以应对全球范围内针对新型原料的碎片化法规结构。这些障碍会延长研发週期,并阻碍精准发酵等新兴技术的商业性化。儘管存在这些营运方面的障碍,但投资环境正在改善。根据良好食品研究所(Good Food Institute)的数据显示,2023年积极投资发酵行业的投资者数量增加了22%。
消费者对益生菌和消化健康解决方案的需求迅速增长,正在从根本上重塑发酵成分市场,使其从单纯的防腐剂跃升为重要的功能性成分。这一转变源于消费者对微生物群在整体健康中作用的认识不断加深,推动了将发酵解决方案融入复杂的医疗和饮食方案的趋势。凯瑞集团于2025年6月进行的一项消费者态度调查也印证了这一趋势,调查发现,69%的受访者表示,同时服用益生菌补充剂带来的消化健康益处是他们继续服用GLP-1类药物的原因之一。这表明,发酵成分正成为现代药物疗法的重要辅助手段,其商业性应用范围也已扩展到传统食品之外。
同时,儘管进入门槛很高,但用于生产替代蛋白的精准发酵技术的快速发展正推动着大规模的产业投资。这项技术无需依赖畜牧业即可生产生物同源蛋白,有效满足了永续性,但它也需要大规模的基建投入。该行业持续吸引强劲的资本流入,以支持其扩张进程。根据良好食品研究所 (Good Food Institute) 2025 年 5 月发布的《行业趋势报告:发酵》显示,该行业展现了强大的财务韧性,截至 2024 年已累计获得 6.51 亿美元的私人融资。为了将这些资金转化为生产能力,各公司正积极投资于实体基础设施建设,例如 Revelation Labs 公司于 2025 年 1 月发行了 5,050 万美元的股票收购权,用于完成其位于印第安纳州的商业规模生物製造工厂的建设。
全球发酵原料市场受到建造和扩大发酵基础设施所需高额资本投入的严重限制。与其他对实体资产需求较低的产业不同,发酵技术在产生可观收益之前,需要对生物反应器、下游加工设备和专用设施进行大量前期投资。这一资金壁垒阻碍了许多公司从试验规模转向商业化生产,造成产能不足,阻碍了创新技术进入市场。因此,新型原料的供应受到限制,导致其单位成本相对于传统商品而言被人为地抬高。
基础设施瓶颈问题因投资环境趋紧而进一步加剧,这限制了资产密集型计划所需的资金流动。资金不足导致企业无法建造大规模生产设施,也无法在价格上与动物性和合成替代品竞争。根据良好食品研究所(Good Food Institute)的数据显示,2024年发酵产业的总资金筹措仅为6.51亿美元,凸显出相对于发展全球基础设施所需的庞大资源而言,该产业的资金投入十分有限。资金短缺直接减缓了新产能的建设速度,并阻碍了发酵衍生原料的广泛商业化。
将生物发酵成分融入「营养美容品」和护肤产品中,正从根本上改变个人护理行业,以永续的高效生物等效物取代合成活性成分。製造商正利用精准发酵技术来设计特定分子,例如低分子量透明质酸,这些分子能够更好地渗透肌肤,同时显着降低资源消耗。生物技术与美容的融合,为满足「洁净标示」的要求开闢了一条可扩展的途径,既不影响产品性能,也不消耗自然资源。根据奇华顿活性美容公司2024年1月发布的新闻稿,该公司精准发酵成分PrimalHyal 50 Life与传统生产方法相比,可将环境影响降低91%。
同时,市场正经历从活性益生菌菌株到稳定后生元成分的重大转变,从而克服了低温运输配送的物流限制。与必须维持活性的益生菌不同,后生元由非活性微生物和生物活性代谢物组成,即使在高温加工和长期储存条件下也能保持其有效性。这使得它们能够被添加到各种常温保存的产品中,例如烘焙点心和饮料。这种转变使得品牌能够将以往仅限于冷藏乳製品的微生物组益处作为功能性成分添加到主流食品中。根据ADM 2024年10月的一项消费者态度调查,89%的美国受访者表示,在了解后生元的健康益处后,他们愿意尝试含有后生元的产品,这印证了这种功能性变革的商业性潜力。
The Global Fermented Ingredients Market is projected to grow from USD 47.08 Billion in 2025 to USD 73.92 Billion by 2031, registering a CAGR of 7.81%. Fermented ingredients, which consist of metabolic byproducts or biomass produced through controlled microbial activity, are utilized to improve flavor, nutritional value, and shelf-stability across various applications. This market expansion is primarily driven by a structural shift toward natural, clean-label preservation methods and the rising industrial demand for sustainable protein alternatives. These drivers are not merely transient trends but are rooted in a need for long-term supply chain sustainability and consumer rejection of synthetic additives, necessitating permanent adjustments in food manufacturing formulations.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 47.08 Billion |
| Market Size 2031 | USD 73.92 Billion |
| CAGR 2026-2031 | 7.81% |
| Fastest Growing Segment | Dry |
| Largest Market | North America |
However, the sector faces a significant challenge regarding the high capital expenditure required to scale fermentation infrastructure and the difficulty of navigating fragmented global regulatory frameworks for novel ingredients. These hurdles can extend development timelines and impede the commercial viability of emerging technologies such as precision fermentation. Despite these operational barriers, the investment landscape is broadening; according to the Good Food Institute, the number of unique investors actively funding the fermentation sector increased by 22% in 2023.
Market Driver
The surge in consumer demand for probiotics and digestive health solutions is fundamentally reshaping the fermented ingredients market, elevating these components from simple preservatives to essential functional agents. This shift is driven by a deepening consumer understanding of the microbiome's role in systemic wellness, leading to the integration of fermented solutions into complex medical and dietary regimens. Highlighting this trend, a June 2025 consumer perception study by Kerry Group found that 69% of participants attributed their continued use of GLP-1 medications to the digestive health benefits provided by concurrent probiotic supplementation, indicating that fermented ingredients are becoming critical adjuncts to modern pharmaceutical therapies and expanding their commercial application beyond traditional food products.
Simultaneously, the rapid expansion of precision fermentation for alternative proteins is catalyzing significant industrial investment despite high entry barriers. This technology enables the production of bio-identical proteins without animal agriculture, effectively addressing sustainability mandates while necessitating substantial infrastructure development. The sector continues to attract robust capital inflows to support this scaling process; according to the Good Food Institute's 'State of the Industry Report: Fermentation' from May 2025, the sector demonstrated financial resilience by raising $651 million in total private funding throughout 2024. To convert this capital into operational capacity, companies are aggressively funding physical infrastructure, as evidenced by Liberation Labs securing $50.5 million in convertible note funding in January 2025 to finalize its commercial-scale biomanufacturing facility in Indiana.
Market Challenge
The Global Fermented Ingredients Market is critically impeded by the high capital expenditure required to establish and scale fermentation infrastructure. Unlike sectors with low physical asset requirements, fermentation necessitates massive upfront investment in bioreactors, downstream processing equipment, and specialized facilities before meaningful revenue can be generated. This financial barrier prevents many companies from transitioning from pilot scale to commercial production, creating a bottleneck where innovative technologies fail to reach the market due to a lack of manufacturing capacity, consequently keeping the supply of novel ingredients constrained and unit costs artificially high compared to conventional commodities.
This infrastructure bottleneck is exacerbated by a tightening investment climate that restricts the flow of capital needed for such asset-heavy projects. Without sufficient funding, companies cannot construct the large-scale facilities necessary to achieve price parity with animal-based or synthetic alternatives. According to the Good Food Institute, the fermentation sector attracted $651 million in total funding in 2024, a figure that highlights a constrained environment relative to the substantial resources required for global infrastructure build-out. This shortfall directly slows the pace at which new capacity can be brought online and stalls the broader commercialization of fermentation-derived ingredients.
Market Trends
The integration of bio-fermented ingredients in "nutri-cosmetics" and skincare is fundamentally altering the personal care sector by replacing chemically synthesized actives with sustainable, high-efficacy bio-equivalents. Manufacturers are increasingly utilizing precision fermentation to engineer specific molecules, such as low-molecular-weight hyaluronic acid, which offer superior skin penetration while drastically lowering resource consumption. This convergence of biotechnology and beauty creates a scalable pathway to meet "clean label" demands without compromising performance or depleting natural resources; according to a January 2024 corporate press release from Givaudan Active Beauty, its precision-fermented ingredient PrimalHyal 50 Life achieved a 91% reduction in environmental impact compared to conventional production methods.
Simultaneously, the market is witnessing a decisive shift from live probiotic strains to stable postbiotic ingredient formulations, overcoming the logistical limitations of cold-chain distribution. Unlike probiotics, which require viability preservation, postbiotics consist of inanimate microorganisms and bioactive metabolites that remain effective under high-heat processing and extended storage conditions, enabling their incorporation into diverse shelf-stable applications like baked goods and beverages. This transition allows brands to functionalize mainstream food products with microbiome benefits previously restricted to chilled dairy. According to an ADM consumer perception study from October 2024, 89% of participants in the United States expressed openness to trying products containing postbiotics based on their perceived health benefits, validating the commercial potential of this functional evolution.
Report Scope
In this report, the Global Fermented Ingredients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Fermented Ingredients Market.
Global Fermented Ingredients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: